Incidence of postoperative complications in breast cancer patients depending on their tumor subtype and type of surgery von Ismagilov, A. Kh, Karasev, V. E., Vyushkov, D. M.

Volltext

A Phase 2 Randomized, Double-Blind, Placebo Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First Line Treatment of Pancreatic Adenocarcinoma von Benson, A., Bendell, J., Wainberg, Z.A., Vyushkov, D., Acs, P., Kudrik, F., Dong, H., Thai, D.

Volltext

618PDA PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF SIMTUZUMAB OR PLACEBO IN COMBINATION WITH GEMCITABINE FOR THE FIRST LINE TREATMENT OF PANCREATIC ADENOCARCINOMA von Benson, A., Bendell, J., Wainberg, Z.A., Vyushkov, D., Acs, P., Kudrik, F., Dong, H., Thai, D.

Volltext

Abituzumab Combined with Cetuximab Plus Irinotecan Versus Cetuximab Plus Irinotecan Alone, as Second-Line Treatment for Patients with KRAS Wild-Type Metastatic Colorectal Cancer: T... von Elez, E., Kocáková, I., Höhler, T., Martens, U., Bokemeyer, C., Van Cutsem, E., Melichar, B., Smakal, M., Cso˝szi, T., Vyushkov, D., Topuzov, E., Orlova, R., Tjulandin, S., Rivera, F., Straub, J., Bruns, R., Quaratino, S., Tabernero, J.

Volltext